ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.71
+0.02 (0.13%)
Sep 17, 2025, 9:35 AM EDT - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $3.75 billion as of September 17, 2025. Its market cap has decreased by -6.60% in one year.
Market Cap
3.75B
Enterprise Value
3.74B
1-Year Change
-6.60%
Ranking
Category
Stock Price
$15.71
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $3.75B, an increase of 7,367.91%. That is a compound annual growth rate of 43.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.74B | -7.65% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |